Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht study

利用机器学习预测2型糖尿病患者使用降糖药物后的血糖控制和生活质量——马斯特里赫特研究

阅读:2

Abstract

BACKGROUND: Despite the heterogeneity of type 2 diabetes (T2D), all patients are treated according to the same guideline. Some people have more difficulty reaching treatment goals (adequate glycaemic control) and maintaining quality of life (QoL). Therefore, a prediction model identifying who is unlikely to reach these goals within the next year would be useful to allow specific attention to these people. AIM: To investigate if machine learning algorithms can predict which individuals are unlikely to reach glycaemic control and likely to deteriorate in QoL in 1 year. METHODS: We used data from The Maastricht Study, including 842 people with T2D and information on HbA1c values, and 964 people with T2D and information on QoL. We evaluated several machine learning algorithms with feature selection methods and hyperparameter tuning in fivefold cross-validation for the corresponding outcomes. RESULTS: The prediction of inadequate glycaemic control showed good performance. The support vector machine classifier performed best in terms of accuracy (0.76 (95% CI 0.71-0.79)), precision (0.79 (95% CI 0.71-0.83)) and area under the receiver operating characteristic curve (AUC-ROC) (0.85 (95% CI 0.80-0.89)). The multi-layer perceptron classifier performed best in terms of recall (0.72 (95% CI 0.64-0.79)) and F1-score (0.73 (95% CI 0.64-0.79)). The prediction of deterioration in QoL showed inadequate performance and did not seem feasible. CONCLUSION: Prediction of glycaemic control after 1 year in T2D is feasible with good model performance. However, the prediction of deterioration in QoL remains a challenge and needs further work.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。